Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
03/07/1996 | CA2198479A1 Method for enhancing immunogenicity, product obtained and pharmaceutical composition |
03/07/1996 | CA2198474A1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle |
03/07/1996 | CA2198473A1 Gene therapy of tumors with an endothelial cell-specific, cell cycle-dependent active compound |
03/07/1996 | CA2198472A1 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle |
03/07/1996 | CA2198362A1 Topical anti-inflammatory composition and method |
03/07/1996 | CA2198080A1 Cell cycle regulated repressor and dna element |
03/07/1996 | CA2196063A1 Cosolvent parenteral formulation of tirilazad |
03/07/1996 | CA2195874A1 Aerosol drug formulations containing polyglycolyzed glycerides |
03/06/1996 | EP0699766A1 Therapeutic antibody based fusion proteins with platelet factor-4 |
03/06/1996 | EP0699439A2 Treatment of diseases caused by sebaceous gland disorders with acyl CoA cholesterol acyl transferase inhibitors |
03/06/1996 | EP0699436A1 Controlled release formulation |
03/06/1996 | EP0699433A2 Cosmetic or pharmaceutical composition containing chitosan derivatives |
03/06/1996 | EP0699432A1 Cosmetic and/or dermatologic composition containing thermal or mineral water and an active agent against acnee or ageing |
03/06/1996 | EP0699079A1 Bioactive and/or targeted dendrimer conjugates |
03/06/1996 | EP0670714A4 Retinoic acid-containing compositions. |
03/06/1996 | EP0630231B1 Liposomes with excess negative charge |
03/06/1996 | EP0395653B1 Synovial phospholipases |
03/06/1996 | CN1118168A Structured copolymers used as absorbents, gels and carriers of metal ions |
03/06/1996 | CN1118160A Polyamine derivatives as radioprotective agents |
03/06/1996 | CN1118143A Excipient stabilization of polypeptides treated with organic solvents |
03/06/1996 | CN1118136A Methods for in vivo delivery of biologics and compositions useful therefor |
03/06/1996 | CN1117875A Composition consisting of a dendrimer and an active substance occluded in the dendrimer, a process for the preparation of such a composition and a process for releasing the active substance |
03/06/1996 | CN1117874A Nasally administrable compositions |
03/06/1996 | CN1117851A Yinhuang Lozenge and its preparation method |
03/05/1996 | US5496934 Nucleic acids encoding a cellulose binding domain |
03/05/1996 | US5496827 Compositions for the transdermal delivery of nutrients |
03/05/1996 | US5496819 Drug delivery |
03/05/1996 | US5496809 Of water, 8-n-(diethylaminoethyl)rebeccamycin and a pharmaceutically acceptable acid |
03/05/1996 | US5496801 Storage stability, mannitol, citric acid buffer |
03/05/1996 | US5496567 Vitamin supplements |
03/05/1996 | US5496565 Microspherules |
03/05/1996 | US5496564 Suspendible composition and process for preparing the same |
03/05/1996 | US5496563 Dry gel composition |
03/05/1996 | US5496561 Time-release agents for drugs from membrane layers of polymers |
03/05/1996 | US5496558 Solid form xerostomia product |
03/05/1996 | US5496557 Wall is composed of two degradable polymers, one permeable to active substance, the other poorly permeable; polymers are poly/ortho/esters, poly-alpha-amino acids, polydepsipeptides, polyanhydrides, polyphosphazenes, copolymers, stereo complexes |
03/05/1996 | US5496549 Bispecific monoclonal antibodies, thrombolytic agent and method of cell lysis |
03/05/1996 | US5496545 Phosphate-binding polymers for oral administration |
03/05/1996 | US5496535 Gas generating agent, improved palatability, magnetic resonance imaging |
03/05/1996 | US5496471 Apparatus for removing components from solutions |
03/05/1996 | CA2010022C Anesthetic oral compositions |
02/29/1996 | WO1996006116A1 Immunoconjugates comprising tyrosine kinase inhibitors |
02/29/1996 | WO1996006114A1 Cytadherence peptides for use in modifying mutual adhesion among eukaryotic cells |
02/29/1996 | WO1996005865A1 Combination immunotoxin/antineoplastic agent therapy for b-lineage cancer |
02/29/1996 | WO1996005864A1 Solid pharmaceutical form for the administration of a liposoluble liquid active substance |
02/29/1996 | WO1996005863A1 Compounds, pharmaceutical composition and diagnostic device comprising same and their use |
02/29/1996 | WO1996005857A1 Device for delivery of substances and methods of use thereof |
02/29/1996 | WO1996005843A1 Pharmaceutical compositions comprising co-dried sucralfate gel and polyalcohol |
02/29/1996 | WO1996005842A1 Intravenous alendronate formulations |
02/29/1996 | WO1996005834A1 Improved pharmaceutical formulations containing ibuprofen and codeine |
02/29/1996 | WO1996005815A1 Oestradiol-containing transdermal therapeutic system comprising hydrophylic additives |
02/29/1996 | WO1996005814A1 Oestradiol transdermal therapeutic system comprising hygroscopic additives |
02/29/1996 | WO1996005812A1 Hydrophilic controlled release device |
02/29/1996 | WO1996005810A1 Drug delivery composition containing chitosan or derivative thereof having a defined z. potential |
02/29/1996 | WO1996005809A1 Improved method for stabilization of biological substances during drying and subsequent storage and compositions thereof |
02/29/1996 | WO1996001128A3 Low-dose steroid tablets containing gallic acid esters as antioxidant agent, process for the manufacture of said tablets, and uses of said tablets |
02/29/1996 | WO1995032735A3 Inverse skewing of the lymphocyte repertoire for therapy and prevention of disease |
02/29/1996 | DE4430601A1 Zelladhäsions-Peptide zur Modifikation des Haftungsverhaltens eukaryontischer Zellen untereinander Cell adhesion peptides to modify the adhesion behavior of eukaryotic cells between each other |
02/29/1996 | DE4429747A1 Cosmetic ointment and cream bases |
02/29/1996 | CA2198207A1 Cell adhesion peptides for use in modifying mutual adhesion among eukaryotic cells |
02/29/1996 | CA2197577A1 Immunoconjugates comprising tyrosine kinase inhibitors |
02/29/1996 | CA2188948A1 Device for delivery of substances and methods of use thereof |
02/28/1996 | EP0698393A1 Solubilizing agent and external preparation containing the same |
02/28/1996 | EP0698389A1 Controlled release matrix for pharmaceuticals |
02/28/1996 | EP0698113A1 Production of toxin binding biopolymers, use thereof |
02/28/1996 | EP0698109A1 Gene transfer into pancreatic and biliary epithelial cells |
02/28/1996 | EP0698040A1 Lhrh antagonists |
02/28/1996 | EP0698018A1 Inclusion complexes of taxol or taxotere or taxus extract formed with cyclodextrins, its preparation and use |
02/28/1996 | EP0697891A1 Polyoxime compounds and their preparation |
02/28/1996 | EP0697890A1 More easily biologically absorbed tablet containing dichloromethylene diphosphonic acid as the active agent |
02/28/1996 | EP0697889A1 COMBINED TREATMENT OF IRON DEPLETION AND IgG ANTIBODY |
02/28/1996 | EP0697887A1 Stable liquid compositions of gamma interferon |
02/28/1996 | EP0697881A1 New cyclosporine-containing pharmaceutical compositions for oral administration |
02/28/1996 | EP0697874A1 Methods of affecting the growth of living tissue in mammals and compounds and compositions therefor |
02/28/1996 | EP0697867A1 Compositions in the form of solid solutions |
02/28/1996 | EP0697866A1 High dose formulations |
02/28/1996 | EP0697860A1 Transdermal therapeutic system containing estradiol |
02/28/1996 | EP0697859A1 Stable, ingestable and absorbable nadh and nadph therapeutic compositions |
02/28/1996 | EP0697858A1 Nasal drug delivery composition containing nicotine |
02/28/1996 | EP0697821A1 Cholesterol lowering drink mix compositions |
02/28/1996 | EP0661966A4 Ulcer prevention and treatment composition and method. |
02/28/1996 | EP0630644A4 Anti-microbial and interferon-inducing pharmaceutical compound. |
02/28/1996 | EP0588897B1 Non-chlorofluorocarbon aerosol formulations |
02/28/1996 | EP0572502A4 Polyamino acid dispersants |
02/28/1996 | EP0547126B1 Biodegradable polymers containing diester units |
02/28/1996 | EP0533836B1 Reversible gelation compositions and methods of use |
02/28/1996 | CN1117383A Cefixime composition |
02/27/1996 | US5494938 Comprisinga water insoluable oil, alkyl glucosides and fatty acid glycerides; storage stability, homogeneity |
02/27/1996 | US5494936 Delivery formulation for probucol |
02/27/1996 | US5494901 Includes carbonic anhydrase inhibitor |
02/27/1996 | US5494683 Surface modified anticancer nanoparticles |
02/27/1996 | US5494682 Encapsulated biomass in crosslinked polymer material |
02/27/1996 | US5494681 Molten blend of active material, spatially oriented matrix comprising wax core material, hydrophobic polymer |
02/27/1996 | US5494680 Transdermal delivery device |
02/27/1996 | US5494679 Molecules for iontophoretic delivery |
02/27/1996 | US5494665 Metal chloride, lysozyme chloride, isotonic agent, nonionic thickening agent and preservative |
02/27/1996 | CA2170505A1 Compositions and methods for the administration of .delta.-aminolevulinic acid and pharmaceutical equivalents thereof |
02/27/1996 | CA2030204C Pharmaceutical compositions of tebufelone |
02/24/1996 | CA2156768A1 Pharmaceutical formulations, their preparation and use |
02/22/1996 | WO1996005320A1 Adenovirus comprising a gene coding for glutathion peroxidase |